• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[同种异体和自体骨髓移植及加强免疫后破伤风类毒素、白喉类毒素、麻疹病毒、脊髓灰质炎病毒和肺炎球菌疫苗抗体的动力学。1:同种异体和自体骨髓移植后破伤风类毒素疫苗抗体的动力学]

[Kinetics of vaccine antibodies to tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococci after allogenic and autologous bone marrow transplantation and booster immunization. 1: The kinetics of vaccine antibodies to tetanus toxoid after allogenic and autologous bone marrow transplantation].

作者信息

Prager J, Baumert A, Hermann J, Fuchs D, Zintl F

机构信息

Universitäts-Kinderklinik, Jussuf Ibrahim, Jena.

出版信息

Kinderarztl Prax. 1992 Jun;60(4-5):124-30.

PMID:1495263
Abstract

Today BMT belongs to the established methods of treatment in haematology and oncology. Because of the constant increase of healthy long-term survivors after BMT the problem of immunological reconstitution and eventual possible late effects gets more and more importance. One problem, which til now has been few attention paid to, is that of the protection by vaccination after BMT. We report on the kinetics of the tetanus-antitoxin in 20 patients after allogeneic or autologous BMT and demonstrate the influence of a graft-versus-host disease and its therapy on the antibody kinetics. In the group of allogeneic transplanted children without a GvHD the tetanus-antitoxin titers felt below their detection range after a time of about 8 months whereas in the group with GvHD this effect already occurred after nearly 4 months. The autologous transplanted patients have a positive antibody level til the time of 20 months after BMT. As a consequence of the lost protection by vaccination after BMT follows the necessity of revaccinations respectively of boostering after immunological reconstitution.

摘要

如今,骨髓移植(BMT)属于血液学和肿瘤学中既定的治疗方法。由于骨髓移植后长期健康存活者不断增加,免疫重建问题以及最终可能出现的晚期效应变得越来越重要。到目前为止,一个很少受到关注的问题是骨髓移植后疫苗接种的保护作用。我们报告了20例异基因或自体骨髓移植患者破伤风抗毒素的动力学情况,并证明了移植物抗宿主病(GvHD)及其治疗对抗体动力学的影响。在没有发生移植物抗宿主病的异基因移植儿童组中,破伤风抗毒素滴度在大约8个月后降至检测范围以下,而在发生移植物抗宿主病的组中,这种效应在近4个月后就已出现。自体移植患者在骨髓移植后20个月时抗体水平仍为阳性。由于骨髓移植后疫苗接种保护作用的丧失,因此有必要在免疫重建后重新接种疫苗或加强免疫。

相似文献

1
[Kinetics of vaccine antibodies to tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococci after allogenic and autologous bone marrow transplantation and booster immunization. 1: The kinetics of vaccine antibodies to tetanus toxoid after allogenic and autologous bone marrow transplantation].[同种异体和自体骨髓移植及加强免疫后破伤风类毒素、白喉类毒素、麻疹病毒、脊髓灰质炎病毒和肺炎球菌疫苗抗体的动力学。1:同种异体和自体骨髓移植后破伤风类毒素疫苗抗体的动力学]
Kinderarztl Prax. 1992 Jun;60(4-5):124-30.
2
[The kinetics of vaccine antibodies against tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococcus after allogeneic and autologous bone marrow transplantation and revaccination. 3: The kinetics of vaccine antibodies against tetanus toxoid and diphtheria toxoid after allogeneic and autologous bone marrow transplantation and combined revaccination against diphtheria and tetanus].[同种异体和自体骨髓移植及再接种后针对破伤风类毒素、白喉类毒素、麻疹病毒、脊髓灰质炎病毒和肺炎球菌的疫苗抗体动力学。3:同种异体和自体骨髓移植及白喉和破伤风联合再接种后针对破伤风类毒素和白喉类毒素的疫苗抗体动力学]
Kinderarztl Prax. 1992 Nov;60(8):230-8.
3
[Kinetics of vaccination antibodies against tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococcus after allogenic and autologous bone marrow transplantation and booster vaccination. 2: Kinetics of vaccination antibodies against diphtheria toxoid after allogenic and autologous bone marrow transplantation].
Kinderarztl Prax. 1992 Oct;60(7):195-8.
4
Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.根据儿童急性淋巴细胞白血病(ALL)协作组05/92方案治疗后的患儿白喉(D)和破伤风(T)抗体值。
Klin Padiatr. 2007 Nov-Dec;219(6):355-60. doi: 10.1055/s-2007-990290.
5
[Vaccination].[疫苗接种]
Klin Padiatr. 2001 Sep;213 Suppl 1:A77-83. doi: 10.1055/s-2001-17503.
6
Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).欧洲急性白血病异基因骨髓移植的结果随时间推移有所改善——欧洲血液和骨髓移植组(EBMT)急性白血病工作组的报告。
Bone Marrow Transplant. 1996 Jan;17(1):13-8.
7
Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.复发性急性淋巴细胞白血病:特定儿童自体和异基因骨髓移植的相似结局
Bone Marrow Transplant. 1996 May;17(5):763-8.
8
Early deaths in children after BMT. Bone Marrow Transplantation Group of the Italian Association for Pediatric Hematology and Oncology (AIEOP) and Gruppo Italiano Trapianto di Midollo Osseo (GITMO).异基因造血干细胞移植后儿童的早期死亡。意大利儿科血液学和肿瘤学协会(AIEOP)骨髓移植组和意大利骨髓移植组(GITMO)。
Bone Marrow Transplant. 1992 Nov;10(5):419-23.
9
A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT.
Bone Marrow Transplant. 1997 May;19(9):933-8. doi: 10.1038/sj.bmt.1700768.
10
Immunity to polioviruses and tetanus after bone marrow transplantation in children.
Pediatr Hematol Oncol. 1994 May-Jun;11(3):331-6. doi: 10.3109/08880019409141677.